Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Second Quarter ended June 30, 2014
Filing Date: July 31, 2014
This filing serves as a cover document announcing the issuance of an Investor News release regarding the Company's second-quarter 2014 results. The detailed financial data is contained in Exhibit 99.1, which is not included in the provided text.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document references the use of non-GAAP financial measures, specifically:
- EBITDA: Operating income excluding interest, taxes, depreciation, and amortization.
- Free Cash Flow: Used to supplement GAAP results.
Reconciliations between these non-GAAP measures and GAAP measures are stated to be included in the attached Investor News and Cash Flow Statement, but the figures themselves are absent from this text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only notes that the non-GAAP measures are included to provide consistency and comparability to prior periods.
Guidance, Outlook, and Risks
Management Commentary: Management states that the non-GAAP measures are provided to enhance the user's understanding of current financial performance and future prospects. They emphasize that these measures should not be used as a substitute for GAAP financial measures.
Risks and Contingencies: The text includes standard legal disclaimers stating that the attached Exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section. No specific operational risks or contingencies are detailed in this cover letter.
Investor Verification Checklist
- Verify the specific Q2 2014 revenue and net income figures in the attached Investor News (Exhibit 99.1).
- Review the reconciliation of EBITDA and Free Cash Flow to GAAP net income to understand adjustments made.
- Confirm year-over-year growth rates and margin trends which are not present in this summary text.
- Check for any updated full-year guidance or outlook statements in the full press release.